MOMA-313

· MOMA Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MOMA-313, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]